[{"NetIncomeLoss_1_Q2_USD":-23679000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-8000.0,"InterestPaidNet_2_Q2_USD":7000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.818,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.825,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":564000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.01,"AccruedLiabilitiesCurrent_0_Q2_USD":7531000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":51508340.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":51342585.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6079000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":11964000.0,"DepreciationAndAmortization_1_Q2_USD":500000.0,"DepreciationAndAmortization_2_Q2_USD":800000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.01,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-193921000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":62382.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q2_USD":10001000.0,"CommonStockSharesIssued_0_Q2_shares":51963770.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":379000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":725000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":466000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_2_Q2_shares":62382.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":228531000.0,"MarketableSecuritiesRealizedGainLoss_1_Q2_USD":1000.0,"MarketableSecuritiesRealizedGainLoss_2_Q2_USD":1000.0,"OperatingLeaseExpense_1_Q2_USD":600000.0,"OperatingLeaseExpense_2_Q2_USD":900000.0,"AssetsCurrent_0_Q2_USD":301532000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":388000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_1_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":189955000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":39000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":1447000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":831000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q2_USD":48835000.0,"CommonStockValue_0_Q2_USD":55000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-414000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":51000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":3521000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":30000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":21000000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1184000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":17651000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":34909000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1974000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1443000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"Liabilities_0_Q2_USD":41029000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":560441000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":225000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":150996000.0,"OtherAssetsNoncurrent_0_Q2_USD":505000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":4103000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-23640000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-44907000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q2_USD":39000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_2_Q2_USD":-8000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-23679000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-44899000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_1_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_1_Q2_USD":0.0,"OperatingLeaseLiability_0_Q2_USD":935000.0,"ShortTermInvestments_0_Q2_USD":141120000.0,"Assets_0_Q2_USD":358054000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":654000.0,"InterestExpense_1_Q2_USD":7000.0,"InterestExpense_2_Q2_USD":7000.0,"AccountsPayableCurrent_0_Q2_USD":23697000.0,"LiabilitiesCurrent_0_Q2_USD":40704000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":487000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":141120000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":151867000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":17064000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2769000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":4928000.0,"RestrictedCashNoncurrent_0_Q2_USD":871000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesOutstanding_0_Q2_shares":51963770.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-234333000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-41885000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":9416000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.81,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.812,"NetIncomeLoss_2_Q2_USD":-44899000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":5657000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":475000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_2_Q2_USD":570000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_1_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":490000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.009,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.005,"StockIssued1_2_Q2_USD":10000000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-44000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.067,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":3965000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":953000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-243463000.0,"ShareBasedCompensation_2_Q2_USD":4634000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-481000.0,"AssetsNoncurrent_0_Q2_USD":56522000.0,"InvestmentIncomeInterest_2_Q2_USD":155000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":3500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":9900000.0,"OperatingIncomeLoss_1_Q2_USD":-23730000.0,"OperatingIncomeLoss_2_Q2_USD":-46873000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"InvestmentIncomeInterest_1_Q2_USD":93000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":398000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":249000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":13.91,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":14.14,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":6370000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"PreferredStockValue_0_Q2_USD":null,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3454000.0,"StockholdersEquity_0_Q2_USD":317025000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":100000.0,"ProfitLoss_2_Q2_USD":-44899000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.46,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.87,"OperatingExpenses_1_Q2_USD":23730000.0,"OperatingExpenses_2_Q2_USD":46873000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":710000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":10585000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1409000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":358054000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q2_USD":2.51,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":2.1,"LongTermInvestments_0_Q2_USD":48835000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":762000.0,"Ticker":"PCVX","CIK":"1649094","name":"VAXCYTE, INC.","OfficialName":"Vaxcyte Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1309224961.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210811"}]